Evidence map›Paper›PMID 39979638›Full record

ArticleNature aging2025

Author Correction: Niche-derived Semaphorin 4A safeguards functional identity of myeloid-biased hematopoietic stem cells.

Dorsa Toghani, Sanika Gupte, Sharon Zeng, Elmir Mahammadov, Edie I Crosse, Negar Seyedhassantehrani, Christian Burns, David Gravano, Stefan Radtke, Hans-Peter Kiem and 27 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors.

Dorsa Toghani *Translational Science and Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Sanika Gupte *Translational Science and Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Sharon ZengTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Elmir MahammadovInstitute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum Muenchen, Munich, Germany.
Edie I CrosseTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Negar SeyedhassantehraniDepartment of Bioengineering, University of California, Merced, Merced, CA, USA.ORCID http://orcid.org/0009-0008-6718-615X
Christian BurnsDepartment of Bioengineering, University of California, Merced, Merced, CA, USA.
David GravanoDepartment of Bioengineering, University of California, Merced, Merced, CA, USA.
Stefan RadtkeTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Hans-Peter KiemTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Sonia RodriguezDepartment of Stem Cell Biology & Regenerative Medicine, Beckman Research Institute of City of Hope, Duarte, CA, USA.
Nadia CarlessoDepartment of Stem Cell Biology & Regenerative Medicine, Beckman Research Institute of City of Hope, Duarte, CA, USA.
Amogh PradeepTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Alexis GeorgiadesTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Fabienne LucasTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Nicola K WilsonDepartment of Haematology, Jeffrey Cheah Biomedical Centre, Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-0865-7333
Sarah J KinstonDepartment of Haematology, Jeffrey Cheah Biomedical Centre, Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Berthold GöttgensDepartment of Haematology, Jeffrey Cheah Biomedical Centre, Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Le ZongEpigenetics and Stem Cell Aging Unit, National Institute of Aging, Baltimore, MD, USA.
Isabel BeermanEpigenetics and Stem Cell Aging Unit, National Institute of Aging, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-7758-8231
Bongsoo ParkEpigenetics and Stem Cell Aging Unit, National Institute of Aging, Baltimore, MD, USA.
Derek H JanssensDepartment of Epigenetics, Van Del Institute, Grand Rapids, MI, USA.
Daniel JonesTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Ali ToghaniTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Claus NerlovRadcliffe Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-0544-735X
Eric M PietrasDepartment of Medicine-Hematology, University of Colorado School of Medicine, Aurora, CO, USA.
Marion MesnieresDepartment of Development and Regeneration, KU Leuven, Leuven, Belgium.
Christa MaesDepartment of Development and Regeneration, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0003-4243-5486
Atsushi KumanogohDepartment of Respiratory Medicine, Allergy and Rheumatic Diseases, University of Osaka, Osaka, Japan.
Thomas WorzfeldFaculty of Medicine, Institute of Pharmacology, University of Marburg, Marburg, Germany.
Jin-Gyu CheongDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Steven Z JosefowiczDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Peter KharchenkoDepartment of Stem Cell and Regenerative Biology, Harvard University, Boston, MA, USA.
David T ScaddenDepartment of Stem Cell and Regenerative Biology, Harvard University, Boston, MA, USA.ORCID http://orcid.org/0000-0001-9821-7133
Antonio ScialdoneInstitute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum Muenchen, Munich, Germany.
Joel A SpencerDepartment of Bioengineering, University of California, Merced, Merced, CA, USA.
Lev SilbersteinTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. lsilbers@fredhutch.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39979638

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.